The Association of Cytokine Genes Polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in Type 2 Diabetes Mellitus-tuberculosis

Authors

  • Mutiara Indah Sari Department of Biochemistry, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
  • Zaimah Z. Tala Departement of Clinical Nutrition, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.5478

Keywords:

IL1β 3954 C/T, IL18-137 G/C, IL18-607 C/A, Polymorphisms, Type 2 diabetes mellitus-tuberculosis, Type 2 diabetes mellitus, Tuberculosis

Abstract

BACKGROUND: The cytokine gene polymorphism is associated with the development of metabolic disorder conditions and infectious diseases such as Type 2 diabetes mellitus (T2DM) and tuberculosis (TB) disease.

AIM: The objective of the study is an attempt to examine the association of cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in T2DM-TB patients.

METHODS: The cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) were investigated in 46 T2DM-TB patients, 46 T2DM patients, and 46 healthy controls. Cytokine genes polymorphism was carried out by the polymerase chain reaction-restriction fragment length polymorphism. Odds ratio (OR) with 95% confidence interval (CI) and p-value was calculated to determine the association between cytokine genes polymorphisms as the risk factor to T2DM-TB development.

RESULTS: No association between genotypes and alleles of cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in T2DM-TB compared to control group (p = 0.434; OR = 0.373; 95% CI = 0.068-2.028 and p = 0.444; OR = 0.387; 95% CI = 0.073–2.046), (p = 0.833; OR = 0.915; 95% CI = 0.400–2.092 and p = 0.864; OR = 1.061; 95% CI = 0.541–2.078), and (p = 0.815; OR = 0.896; 95% CI = 0.357–2.246 and p = 0.882; OR = 0.957; 95% CI = 0.534–1.715). This study also found no association between genotypes and alleles of cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) with T2DM-TB compared to T2DM group (p = 1; OR = 0.652; 95% CI = 0.104–4.094 and p = 1; OR = 0.659; 95% CI = 0.108–4.041), (p = 0.189; OR = 1.786; 95% CI = 0.749–4.262 and p = 0.098; OR = 1.857; 95% CI = 0.887–3.889), and (p = 0.374; OR = 1.488; 95% CI = 0619–3.579 and p = 0.365; OR = 1.316; 95% CI=0.727–2.382).

CONCLUSION: There is no association of the cytokine genes polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in T2DM-TB compared to control and T2DM groups, and all cytokine genes polymorphisms not as the risk factor to T2DM-TB development in this population.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: Convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737- 46. https://doi.org/10.1016/s1473-3099(09)70282-8 PMid:19926034 DOI: https://doi.org/10.1016/S1473-3099(09)70282-8

World Health Organization. Global Tuberculosis Report. Geneva: World Health Organization; 2019. Available from: https://www.who.int/tb/publications/global_report/en. [Last accessed on 2020 Jan 15].

Niazi AK, Kalra S. Diabetes and tuberculosis: A review of the role of optimal glycemic control. J Diabetes Metab Disord. 2012;11(1):28. https://doi.org/10.1186/2251-6581-11-28 PMid:23497638 DOI: https://doi.org/10.1186/2251-6581-11-28

Baghaei P, Marjani M, Javanmard P, Tabarsi P, Masjedi MR. Diabetes mellitus and tuberculosis facts and controversies. J Diabetes Metab Disord. 2013;12(1):58. https://doi.org/10.1186/2251-6581-12-58 PMid:24360398 DOI: https://doi.org/10.1186/2251-6581-12-58

Banerjee M, Saxena M. Genetic polymorphisms of cytokine genes in Type 2 diabetes mellitus. World J Diabetes. 2014;5(4):493-504. https://doi.org/10.4239/wjd.v5.i4.493 PMid:25126395 DOI: https://doi.org/10.4239/wjd.v5.i4.493

Huang Y, Xu M, Hong J, Gu W, Bi Y, Li X. -607 C/A polymorphism in the promoter of IL-18 gene is associated with 2h post-loading plasma glucose level in Chinese. Endocrine. 2010;37(3):507- 12. https://doi.org/10.1007/s12020-010-9338-0 PMid:20960175 DOI: https://doi.org/10.1007/s12020-010-9338-0

Bai L, Wang D, Zhai Q, Wang J, Hai J, Jin S, et al. Association of interleukin-18 polymorphisms and the susceptibility to diabetic nephropathy. Int J Clin Exp Pathol. 2016;9(10):10522-8.

Han M, Jun Y, Lian YY, Zhao YL, Wang HX, Liu LR. Relationship between single nucleotide polymorphism of interleukin-18 and susceptibility to pulmonary tuberculosis in the Chinese Han population. Microbiol Immunol. 2011;55(6):388-93. https://doi.org/10.1111/j.1348-0421.2011.00332.x PMid:21395662 DOI: https://doi.org/10.1111/j.1348-0421.2011.00332.x

Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. Infect Immun. 2012;80(10):3343- 59. https://doi.org/10.1128/iai.00443-12 PMid:22825450 DOI: https://doi.org/10.1128/IAI.00443-12

Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest. 1992;22(6):396-402. https://doi.org/10.1111/j.1365-2362.1992. tb01480.x PMid:1353022 DOI: https://doi.org/10.1111/j.1365-2362.1992.tb01480.x

Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6(4):232-41. https://doi.org/10.1038/nrrheum.2010.4 PMid:20177398 DOI: https://doi.org/10.1038/nrrheum.2010.4

Ponnana M, Sivangala R, Joshi L, Valluri V, Gaddam S. IL-6 and IL-18 cytokine gene variants of pulmonary tuberculosis patients with co-morbid diabetes mellitus and their household contacts in Hyderabad. Gene. 2017;627:298-306. https://doi.org/10.1016/j. gene.2017.06.046 PMid:28652186 DOI: https://doi.org/10.1016/j.gene.2017.06.046

Perhimpunan Dokter Paru Indonesia. Tuberkulosis: Pedoman Diagnosis dan Penatalaksanaan di Indonesia. Jakarta: Indah Offset Citra Grafika; 2011.

Perkumpulan Endokrinologi Indonesia (Perkeni). Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2015. Pengurus Besar Perkumpulan Endokrinologi Indonesia (PB Perkeni); 2015. Available from: https://www. pbperkeni.or.id/wp-content/uploads/2019/01/4.-KonsensusPengelolaan-dan-Pencegahan-Diabetes-melitus-tipe-2-diIndonesia-PERKENI-2015.pdf. https://doi.org/10.23886/ejki.3.4810. [Last accessed on 2020 Jun 12].

Meenakshi P, Ramya S, Shruthi T, Lavanya J, Mohammed HH, Mohammed SA, et al. Association of IL-1β+ 3954 C/T and IL-10- 1082 G/A cytokine gene polymorphisms with susceptibility to tuberculosis. Scand J Immunol. 2013;78(1):92-7. https://doi.org/10.1111/sji.12055 PMid:23654353 DOI: https://doi.org/10.1111/sji.12055

Bakr NM, Hashim NA, Awad A, Sarhan AA. Association between interleukin-18 promoter polymorphisms and risk of ischemic stroke: A case-control study. Egyp J Med Hum Genet. 2017;19(1):13-8. https://doi.org/10.1016/j.ejmhg.2017.08.014 DOI: https://doi.org/10.1016/j.ejmhg.2017.08.014

Andrews CA. The hardy Weinberg principle. Nat Educ Knowledge. 2010;3(10):65. Available from: https://www. nature.com/scitable/knowledge/library/the-hardy-weinbergprinciple-13235724/#:~:text=The%20Hardy%2DWeinberg%20 Equilibrium&text=The%20Hardy%2DWeinberg%20 Theorem%20deals,change%20from%20generation%20to%20 generation. [Last accessed on 2020 Feb 10].

Hall NB, Igo RP Jr., Malone LL, Truitt B, Schnell A, Tao L, et al. Polymorphisms in TICAM2 and IL1B are associated with TB. Genes Immun. 2015;16(2):127-33. https://doi.org/10.1038/gene.2014.77 PMid:25521228 DOI: https://doi.org/10.1038/gene.2014.77

Wu S, Wang Y, Zhang M, Shrestha SS, Wang M, He JQ. Genetic polymorphisms of IL1B, IL6, and TNFα in a Chinese Han population with pulmonary tuberculosis. Biomed Res Int. 2018;2018:3010898. https://doi.org/10.1155/2018/3010898 DOI: https://doi.org/10.1155/2018/3010898

Wu S, Wang M, Wang Y, He JQ. Polymorphisms of cytokine genes and tuberculosis in two independent studies. Sci Rep. 2019;9(1):2507. DOI: https://doi.org/10.1038/s41598-019-39249-4

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I. Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes Type 2 and the metabolic syndrome: An observational study. Cardiovasc Diabetol. 2011;10:110. https://doi.org/10.1186/1475-2840-10-110 PMid:22141572 DOI: https://doi.org/10.1186/1475-2840-10-110

Zhou LH, Sheng YF. IL-18 polymorphisms (-137C/G and -607A/C) are not associated with tuberculosis. Innate Immun. 2019;25(7):444-50. https://doi.org/10.1177/1753425919861670 DOI: https://doi.org/10.1177/1753425919861670

Ismail S, Essawi M. Genetic polymorphism studies in humans. Middle East J Med Genet. 2012;1(2):57-63. https://doi.org/10.1097/01.mxe.0000415225.85003.47 DOI: https://doi.org/10.1097/01.MXE.0000415225.85003.47

Cooper AM, Mayer-Barber KD, Sher A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 2011;4(3):252-60. https://doi.org/10.1038/mi.2011.13 PMid:21430655 DOI: https://doi.org/10.1038/mi.2011.13

Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005;12(5):255-69. https://doi.org/10.1159/000087104 PMid:16166805 DOI: https://doi.org/10.1159/000087104

Ayelign B, Negash M, Genetu M, Wondmagegn T, Shibabaw T. Immunological impacts of diabetes on the susceptibility of Mycobacterium tuberculosis. J Immunol Res. 2019;2019:6196532. https://doi.org/10.1155/2019/6196532 DOI: https://doi.org/10.1155/2019/6196532

Kumar NP, Babu S. Influence of diabetes mellitus on immunity to human tuberculosis. Immunology. 2017;152(1):13-24. https://doi.org/10.1111/imm.12762 PMid:28543817 DOI: https://doi.org/10.1111/imm.12762

Downloads

Published

2020-11-12

How to Cite

1.
Sari MI, Tala ZZ. The Association of Cytokine Genes Polymorphisms (IL1β+3954 C/T, IL18-137 G/C, and IL18-607 C/A) in Type 2 Diabetes Mellitus-tuberculosis. Open Access Maced J Med Sci [Internet]. 2020 Nov. 12 [cited 2024 May 26];8(A):910-5. Available from: https://oamjms.eu/index.php/mjms/article/view/5478

Most read articles by the same author(s)

1 2 > >>